# An Observational Study to Evaluate the Effectiveness of Mircera Treatment for Renal Anemia in Pre-dialysis Participants With Chronic Kideny Disease (CKD)

> **NCT02547454** · — · COMPLETED · sponsor: **Hoffmann-La Roche** · enrollment: 393 (actual)

## Conditions studied

- Kidney Disease, Chronic

## Interventions

- **DRUG:** Methoxy polyethylene glycol-epoetin beta

## Key facts

- **NCT ID:** NCT02547454
- **Lead sponsor:** Hoffmann-La Roche
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2008-12-31
- **Primary completion:** 2014-11-30
- **Final completion:** 2014-11-30
- **Target enrollment:** 393 (ACTUAL)
- **Last updated:** 2017-06-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02547454

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02547454, "An Observational Study to Evaluate the Effectiveness of Mircera Treatment for Renal Anemia in Pre-dialysis Participants With Chronic Kideny Disease (CKD)". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT02547454. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*